Skip to main content
logo
Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
400.43
+4.11 (1.04%)
At close: Nov 4, 2026, 4:00 PM EST
395.01
-5.42 (-1.35%)
Pre-market: Nov 5, 2026, 7:47 AM EST

Madrigal Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-155.46-288.28-465.89-373.63-295.35-241.85
Depreciation & Amortization
5.014.721.10.530.470.41
Other Amortization
1.861.62.092.410.8-
Stock-Based Compensation
134.1298.1379.8849.7431.6326.87
Other Operating Activities
5.942.78-0.4---
Change in Accounts Receivable
-114.11-80.65-53.82---
Change in Inventory
-60.53-36.98-34.07---
Change in Accounts Payable
16.815.2815.564.212.4520.36
Change in Other Net Operating Assets
9.35103.86-0.01-7.4935.1510.29
Operating Cash Flow
-157.01-189.55-455.57-324.23-224.86-183.92
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-11.64-0.47-1.46-1.48-0.22-0.21
Sale (Purchase) of Intangibles
--3-5---
Investment in Securities
359.435.79-267.92-501.04206.9-4.85
Investing Cash Flow
347.7632.32-274.39-502.52206.69-5.06

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-350-6550-
Total Debt Issued
-350-6550-
Long-Term Debt Repaid
--121.66----
Net Debt Issued (Repaid)
-228.34-6550-
Issuance of Common Stock
25.3538.06735.06530.48264.34171.24
Other Financing Activities
-0.98-10.41--0.36-0.89-
Financing Cash Flow
24.36255.98735.06595.12313.45171.24

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.360.01----
Net Cash Flow
214.7598.765.1-231.63295.28-17.74

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-168.65-190.02-457.03-325.71-225.07-184.13
Free Cash Flow Growth
------
Free Cash Flow Margin
-11.81%-19.83%-253.72%---
Free Cash Flow Per Share
-7.31-8.47-21.48-17.43-13.13-11.13
Levered Free Cash Flow
-112.43-115.08-296.99-192.38-115.68-94.62
Unlevered Free Cash Flow
-94.21-102.74-289.91-186.85-114-94.62

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-148.48-8.5-72.35-3.2837.630.65
SEC Filings: 10-K · 10-Q